FDA Launches Effort to Prevent Next Heparin Crisis with Public Meeting
This article was originally published in The Gold Sheet
Executive Summary
FDA meeting intended to ward off another heparin crisis but without accidentally enabling one. FDA describes multifaceted nature of the challenge and poses questions for the May 1 meeting.